ID

29073

Description

Study ID: 101468/249 Clinical Study ID: 101468/249 Study Title: A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363857 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: N/A Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome; Restless Legs Syndrome (RLS)

Keywords

  1. 2/23/18 2/23/18 -
Copyright Holder

GlaxoSmithKline (GSK)

Uploaded on

February 23, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Clinical Study, Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS), Study ID: 101468/249, NCT00363857

Abnormal findings at the Screening Visit

Administration
Description

Administration

Alias
UMLS CUI-1
C1320722
Patient number
Description

Patient number

Data type

integer

Alias
UMLS CUI [1]
C1830427
Visit date
Description

Visit date

Data type

date

Alias
UMLS CUI [1]
C1320303
Center Number
Description

Center Number

Data type

integer

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Electrocardiogram (12 lead)
Description

Electrocardiogram (12 lead)

Alias
UMLS CUI-1
C0430456
Date of ECG
Description

Dato of ECG

Data type

date

Alias
UMLS CUI [1]
C2826640
Were any clinically significant abnormalities detected?
Description

If ’Yes’, please record details in the Baseline Signs and Symptoms and/or SAE section at the back of this book and exclude the patient from the study.

Data type

integer

Alias
UMLS CUI [1]
C0522055
Laboratory evaluation
Description

Laboratory evaluation

Alias
UMLS CUI-1
C0022885
Date of sample
Description

Date of sample

Data type

date

Alias
UMLS CUI [1]
C1302413
Were any clinically significant abnormalities detected?
Description

If ‘Yes’, please record the findings and/or diagnosis in the Baseline Signs and Symptoms and/or SAE section at the back of this book and exclude the patient from the study.

Data type

integer

Alias
UMLS CUI [1]
C1853129

Similar models

Abnormal findings at the Screening Visit

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administration
C1320722 (UMLS CUI-1)
Patient number
Item
Patient number
integer
C1830427 (UMLS CUI [1])
Visit date
Item
Visit date
date
C1320303 (UMLS CUI [1])
Center Number
Item
Center Number
integer
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Item Group
Electrocardiogram (12 lead)
C0430456 (UMLS CUI-1)
Dato of ECG
Item
Date of ECG
date
C2826640 (UMLS CUI [1])
Item
Were any clinically significant abnormalities detected?
integer
C0522055 (UMLS CUI [1])
Code List
Were any clinically significant abnormalities detected?
CL Item
No (1)
CL Item
Yes (2)
Item Group
Laboratory evaluation
C0022885 (UMLS CUI-1)
Date of sample
Item
Date of sample
date
C1302413 (UMLS CUI [1])
Item
Were any clinically significant abnormalities detected?
integer
C1853129 (UMLS CUI [1])
Code List
Were any clinically significant abnormalities detected?
CL Item
No (1)
CL Item
Yes (2)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial